Trial Profile
An Observational Study to the Patients With Alzheimer's Disease Who Previously Received UB311-Treatment in the V118-AD Trial
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Nov 2017
Price :
$35
*
At a glance
- Drugs UB 311 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors United Biomedical